GlassScriptPhysician profile
Surya R Kumar
NPI 1154470466
$3,675.33
in general payments reported to CMS, 2019-2025
29 companies · $377 in 2025
The $377 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $372 · 2021: $524 · 2022: $18.35 · 2023: $616 · 2024: $1,768 · 2025: $377.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,761.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,760.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endologix LLC | $935.03 | 2021-2024 | Endocross Device, Torus Stent Graft System, Afx2 Bifurcated Endograft System |
| Boston Scientific Corporation | $322.38 | 2023-2024 | Watchman Flx |
| Medtronic Vascular, INC. | $281.55 | 2019 | |
| Bard Peripheral Vascular, INC. | $278.88 | 2023-2024 | Lutonix Drug Coated Balloon |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $197.32 | 2021-2024 | Lifevest |
| Ethicon US, LLC | $174.46 | 2024-2025 | Echelon Circular, Surgicel Nu-Knit, Stratafix |
| Medtronic, INC. | $147.72 | 2021-2024 | Octopus |
| Terumo Medical Corporation | $141.45 | 2024 | Azur Cx Detachable |
| Penumbra, INC. | $134.09 | 2024 | Indigo System |
| Lilly USA, LLC | $125.00 | 2025 | Jardiance |
| Emd Serono, INC. | $121.20 | 2021 | |
| Abbvie INC. | $110.00 | 2021 | |
| Cook Medical LLC | $93.38 | 2024 | Zilver Ptx |
| Lemaitre Vascular, INC. | $90.32 | 2019 | |
| Smith+Nephew, INC. | $80.29 | 2023 | Renasys Go V2 Home, Pico 7 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $72.49 | 2023-2025 | Verquvo |
| Abiomed | $61.66 | 2024-2025 | Impella |
| Mimedx Group, INC. | $46.30 | 2025 | |
| Kiniksa Pharmaceuticals International, Plc | $44.67 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $39.70 | 2021-2022 | |
| Lexicon Pharmaceuticals, INC. | $31.01 | 2023-2024 | Inpefa |
| Kerecis Limited | $29.10 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.28 | 2023 | Jardiance |
| Atricure, INC. | $20.03 | 2024 | |
| Kls-Martin L.P. | $18.07 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $16.74 | 2024 | Opsumit, Uptravi |
| Esperion Therapeutics, INC. | $13.99 | 2023 | Nexletol |
| Cvrx, INC. | $13.25 | 2024 | Barostim Neo System |
| Astrazeneca Pharmaceuticals LP | $12.97 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Surya Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.